蛋白酶激活受体2在损伤中的许多方面
Yuji Oe1, Tetsuhiro Tanaka1, Nobuyuki Takahashi2
1Department of Nephrology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
Biomedicines
|February 26, 2025
概括
蛋白酶激活受体2 (PAR2) 通过促进炎症和纤维化,在损伤中发挥关键作用. 了解 PAR2 的理解
科学领域:
- 腎病學和分子生物學.
- 在病理生理学中的G蛋白结合受体信号传递.
背景情况:
- 蛋白酶激活受体2 (PAR2) 是一种由血清蛋白酶激活的G蛋白结合受体.
- PAR2激活会影响炎症和纤维化通路,包括NF-κB和MAPK级联.
- 越来越多的证据表明,PAR2在各种病情境中参与其中.
研究的目的:
- 审查和综合有关PAR2在病中的作用的当前文献.
- 巩固对PAR2在病理生理学中的机制和影响的理解.
主要方法:
- 在病模型中研究PAR2的综合文献综述.
- 对研究的分析,重点是通过诸如因子VIIa和XA之类的蛋白酶激活PAR2.
- 检查PAR2在脏内的炎症和纤维性反应中的作用.
主要成果:
- PAR2与加强脏中的炎症和纤维性反应有关.
- PAR2的激活与核因子-kappa B和基因激活蛋白激酶等途径有关.
- 在急性损伤,纤维化,糖尿病病,衰老和血栓性微血管病变中报告了PAR2的作用.
结论:
- PAR2代表了缓解损伤的潜在治疗标.
- 需要进一步研究PAR2在病中的多方面的作用.
- 向PAR2可能为治疗各种病理提供新的策略.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
469
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
469
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
452
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
452
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
568
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
568
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
370
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
370